Jeffrey A. Alexander
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeffrey A. Alexander has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
David A. Katzka
Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN USA
5 shared publicationsKarthik Ravi
Division of Gastroenterology and Hepatology Mayo Clinic Rochester Minnesota USA
5 shared publications- David A. Katzka
Division of Digestive and Liver Diseases Columbia University Irving Medical Center New York New York USA
4 shared publications - Joseph Anthony Murray
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
4 shared publications Lori A. Kryzer
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA
4 shared publicationsD. Katzka
Division of Gastroenterology, Mayo Clinic, Rochester, MN, USA
3 shared publications
Latest Publications
- 16 October 2023
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 58 (11-12) , 1143-1150
Development of a model to identify patients who do not need oesophageal biopsies when eosinophilic oesophagitis is suspected
Summary: Background: Predictive models for eosinophilic oesophagitis (EoE) may not fully rule in the diagnosis.Aim: To develop a reverse model that predicts against EoE to eliminate the need for oesophageal biopsies.Methods: In this two‐centre study, a predictive model was developed (Mayo Clinic) and validated (University of North Carolina [UNC]). Cross‐sectional data from consecutive adult patients without prior EoE who underwent upper enoscopy with oesophageal biopsies were used. EoE cases had ≥15 eosinophils/high‐power field while controls had no eosinophils. Data were collected on patient clinical and endoscopic features. Multiple variable logistic regression was used to identify predictors of non‐EoE status while maintaining specificity ≥95%. A secondary model was developed to predict against the need for endoscopy in patients suspected of having EoE without alarm symptoms.Results: The Mayo and UNC cohorts consisted of 345 (EoE = 94, non‐EoE = 251) and 297 patients (EoE = 84, non‐EoE = 213), respectively. A primary model based on clinical and endoscopic features predicted against EoE with c‐statistic 0.92 (95% CI: 0.88–0.96), specificity 95%, and sensitivity 65%. This model was validated (UNC) with c‐statistic 0.87 (95% CI: 0.82–0.92). A simplified scoring system was created and a threshold of ≥12 points excluded EoE with 95% specificity and 50% sensitivity. A secondary model based on clinical characteristics alone predicted against EoE with c‐statistic 0.86 (95% CI: 0.82–0.90), specificity 95% and sensitivity 39% and validated (UNC) with c‐statistic 0.78 (95% CI: 0.71–0.85).Conclusion: A simplified scoring system accurately identified a group of patients with a low likelihood of EoE where unnecessary oesophageal biopsies can be avoided, potentially resulting in resource and cost savings.
- 16 October 2023
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 58 (11-12) , 1143-1150
Development of a model to identify patients who do not need oesophageal biopsies when eosinophilic oesophagitis is suspected
Summary: Background: Predictive models for eosinophilic oesophagitis (EoE) may not fully rule in the diagnosis.Aim: To develop a reverse model that predicts against EoE to eliminate the need for oesophageal biopsies.Methods: In this two‐centre study, a predictive model was developed (Mayo Clinic) and validated (University of North Carolina [UNC]). Cross‐sectional data from consecutive adult patients without prior EoE who underwent upper enoscopy with oesophageal biopsies were used. EoE cases had ≥15 eosinophils/high‐power field while controls had no eosinophils. Data were collected on patient clinical and endoscopic features. Multiple variable logistic regression was used to identify predictors of non‐EoE status while maintaining specificity ≥95%. A secondary model was developed to predict against the need for endoscopy in patients suspected of having EoE without alarm symptoms.Results: The Mayo and UNC cohorts consisted of 345 (EoE = 94, non‐EoE = 251) and 297 patients (EoE = 84, non‐EoE = 213), respectively. A primary model based on clinical and endoscopic features predicted against EoE with c‐statistic 0.92 (95% CI: 0.88–0.96), specificity 95%, and sensitivity 65%. This model was validated (UNC) with c‐statistic 0.87 (95% CI: 0.82–0.92). A simplified scoring system was created and a threshold of ≥12 points excluded EoE with 95% specificity and 50% sensitivity. A secondary model based on clinical characteristics alone predicted against EoE with c‐statistic 0.86 (95% CI: 0.82–0.90), specificity 95% and sensitivity 39% and validated (UNC) with c‐statistic 0.78 (95% CI: 0.71–0.85).Conclusion: A simplified scoring system accurately identified a group of patients with a low likelihood of EoE where unnecessary oesophageal biopsies can be avoided, potentially resulting in resource and cost savings.
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S188
Following Peroral Endoscopic Myotomy (POEM) for Achalasia Esophagram is a Reliable Predictor of Esophageal Contents on EGD
Aims Peroral endoscopic myotomy (POEM) treats achalasia, but patients have higher risk of gastroesophageal reflux (GER) compared to Heller myotomy. Post-POEM endoscopic GER screening is recommended to identify those at risk for reflux-related complications. Due to aspiration risk, endotracheal (ET) intubation is performed on achalasia patients for EGD, though it is unclear if the risk remains after POEM. We aimed to determine if esophagram ≥3 months post-POEM could predict the presence of esophageal contents on EGD. Methods We identified patients who underwent POEM from 01/2021-08/2022 with follow-up EGD ≥3 months later. Protocol requires achalasia patients to avoid solids for 2 days and NPO for 8 hours before endoscopy. Demographics were abstracted from the electronic medical record. Results 33 patients underwent POEM, 25 had follow-up esophagram and EGD. Most had type 2 achalasia (64.0%) with a pre-POEM mean Eckardt score of 6.2 (SD 2.2), indicating moderate to severe disease. Post-POEM mean Eckardt score decreased to 1.5 (SD 1.2). 56% of patients received ET intubation during follow-up EGD. In patients where the 13mm barium tablet passed the GEJ (N=14), none had esophageal contents ([Table 1]). In patients whose standing barium column at 5 min was <10cm, 10.5% (N=2) had esophageal contents. ROC curve for column height as a predictor of esophageal contents with AUC 0.91. Conclusions Following POEM, adequate GEJ passage of a 13mm barium tablet and 5 minute standing barium column height of less than 7.1cm, were predictors of an empty esophagus during follow-up EGD. This select group may not require endotracheal intubation on subsequent EGD in the presence of improved dysphagia (Fig. 1). [Table 1]. Outcomes after POEM. POEM: Peroral Endoscopic Myotomy; SD: Standard deviation; BMI: Body mass index; IQR: Interquartile range; GEJ: Gastroesophageal junction; EGD: Esophagogastroduodenoscopy Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S188
Following Peroral Endoscopic Myotomy (POEM) for Achalasia Esophagram is a Reliable Predictor of Esophageal Contents on EGD
Aims Peroral endoscopic myotomy (POEM) treats achalasia, but patients have higher risk of gastroesophageal reflux (GER) compared to Heller myotomy. Post-POEM endoscopic GER screening is recommended to identify those at risk for reflux-related complications. Due to aspiration risk, endotracheal (ET) intubation is performed on achalasia patients for EGD, though it is unclear if the risk remains after POEM. We aimed to determine if esophagram ≥3 months post-POEM could predict the presence of esophageal contents on EGD. Methods We identified patients who underwent POEM from 01/2021-08/2022 with follow-up EGD ≥3 months later. Protocol requires achalasia patients to avoid solids for 2 days and NPO for 8 hours before endoscopy. Demographics were abstracted from the electronic medical record. Results 33 patients underwent POEM, 25 had follow-up esophagram and EGD. Most had type 2 achalasia (64.0%) with a pre-POEM mean Eckardt score of 6.2 (SD 2.2), indicating moderate to severe disease. Post-POEM mean Eckardt score decreased to 1.5 (SD 1.2). 56% of patients received ET intubation during follow-up EGD. In patients where the 13mm barium tablet passed the GEJ (N=14), none had esophageal contents ([Table 1]). In patients whose standing barium column at 5 min was <10cm, 10.5% (N=2) had esophageal contents. ROC curve for column height as a predictor of esophageal contents with AUC 0.91. Conclusions Following POEM, adequate GEJ passage of a 13mm barium tablet and 5 minute standing barium column height of less than 7.1cm, were predictors of an empty esophagus during follow-up EGD. This select group may not require endotracheal intubation on subsequent EGD in the presence of improved dysphagia (Fig. 1). [Table 1]. Outcomes after POEM. POEM: Peroral Endoscopic Myotomy; SD: Standard deviation; BMI: Body mass index; IQR: Interquartile range; GEJ: Gastroesophageal junction; EGD: Esophagogastroduodenoscopy Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 29 January 2023
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 57 (4) , 445
Letter: diet‐responsive or just diet‐adherent in EoE. Where is the dietitian? Authors' reply
- 29 January 2023
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 57 (4) , 445
Letter: diet‐responsive or just diet‐adherent in EoE. Where is the dietitian? Authors' reply
- Open Access
- 21 September 2022
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 13 (11) , e00534
Eosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis
INTRODUCTION: We aimed to assess the diagnostic utility of eosinophil peroxidase (EPX) staining on Cytosponge (CS) samples in eosinophilic esophagitis (EoE). METHODS: Esophageal biopsy (BX) samples from adult subjects with EoE were assessed using peak eosinophils per high-power field (eos/hpf), EPX, and the EoE histologic scoring system. EPX staining and eos/hpf were compared (BX vs CS). RESULTS: CS EPX positivity correlated with eos/hpf (CS [r = 0.82, P < 0.0001]; BX [r = 0.65, P < 0.0001]) and EoE histologic scoring system (grade [r = 0.62, P < 0.00001]; stage [r = 0.61, P < 0.0001]). CS EPX identified subjects with active EoE (area under the curve = 0.86, P < 0.0001). DISCUSSION: The correlation of CS EPX with eosinophilic inflammation and histologic disease severity supports its diagnostic utility in EoE.
- 21 September 2022
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 13 (11) , e00534
Open AccessEosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis
INTRODUCTION: We aimed to assess the diagnostic utility of eosinophil peroxidase (EPX) staining on Cytosponge (CS) samples in eosinophilic esophagitis (EoE). METHODS: Esophageal biopsy (BX) samples from adult subjects with EoE were assessed using peak eosinophils per high-power field (eos/hpf), EPX, and the EoE histologic scoring system. EPX staining and eos/hpf were compared (BX vs CS). RESULTS: CS EPX positivity correlated with eos/hpf (CS [r = 0.82, P < 0.0001]; BX [r = 0.65, P < 0.0001]) and EoE histologic scoring system (grade [r = 0.62, P < 0.00001]; stage [r = 0.61, P < 0.0001]). CS EPX identified subjects with active EoE (area under the curve = 0.86, P < 0.0001). DISCUSSION: The correlation of CS EPX with eosinophilic inflammation and histologic disease severity supports its diagnostic utility in EoE.
- 10 June 2022
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (2) , 299-306.e3
Use of the Esophageal Sponge in Directing Food Reintroduction in Eosinophilic Esophagitis
- 10 June 2022
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (2) , 299-306.e3
Use of the Esophageal Sponge in Directing Food Reintroduction in Eosinophilic Esophagitis
- Open Access
- 23 October 2020
- Published by Hindawi Limited in GastroHep
- Vol. 2 (6) , 272-280
Stable interval bone density in patients with eosinophilic oesophagitis on topical steroids
Objective This study was undertaken to evaluate the effects of maintenance topical steroids (TS) used for treatment in adult patients with eosinophilic esophagitis (EoE) on bone health. Patients and Methods We performed a retrospective review of patients with EoE (≥15 eosinophils/HPF on esophageal biopsy) who were seen in the Esophageal Clinic between January 1, 2013 and May 31, 2020, treated with maintenance TS for ≥one year and underwent bone health evaluation. Dual energy X‐ray absorptiometry (DEXA) scans were obtained during steroid induction therapy, with follow up studies obtained at least one year later. Demographic, laboratory, radiographic, endoscopic and histologic findings were reviewed. Results 21 patients had baseline and follow up DEXA scans (mean age of 44 years, slight male predominance (61.9%)). TS regimens included Budesonide‐Rincinol gel and Budesonide capsules mixed into slurry (induction dose range from 1.5 mg‐6 mg total daily, maintenance dose range from 0.5‐6 mg total daily). Mean follow up between initial and final DEXA was 707±391 days. Mean (±SD) baseline T‐score, Z‐score, and BMD (from spine, hips and femurs) (g/cm2) was ‐0.3±1.09, ‐0.06±0.93, and 1.05±0.15 respectively. Mean (±SD) change in bone mineral density was +0.38%±1.5% with mean change in absolute BMD of ‐0.01±0.04 g/cm2 (p=0.3). One patient progressed from normal BMD to osteopenia and none from osteopenia to osteoporosis. Conclusion Chronic maintenance steroid therapy in this pilot study does not appear to induce significant change in BMD in patients with EoE. Larger and longer trials are needed to validate these conclusions.
- 23 October 2020
- Published by Hindawi Limited in GastroHep
- Vol. 2 (6) , 272-280
Open AccessStable interval bone density in patients with eosinophilic oesophagitis on topical steroids
Objective This study was undertaken to evaluate the effects of maintenance topical steroids (TS) used for treatment in adult patients with eosinophilic esophagitis (EoE) on bone health. Patients and Methods We performed a retrospective review of patients with EoE (≥15 eosinophils/HPF on esophageal biopsy) who were seen in the Esophageal Clinic between January 1, 2013 and May 31, 2020, treated with maintenance TS for ≥one year and underwent bone health evaluation. Dual energy X‐ray absorptiometry (DEXA) scans were obtained during steroid induction therapy, with follow up studies obtained at least one year later. Demographic, laboratory, radiographic, endoscopic and histologic findings were reviewed. Results 21 patients had baseline and follow up DEXA scans (mean age of 44 years, slight male predominance (61.9%)). TS regimens included Budesonide‐Rincinol gel and Budesonide capsules mixed into slurry (induction dose range from 1.5 mg‐6 mg total daily, maintenance dose range from 0.5‐6 mg total daily). Mean follow up between initial and final DEXA was 707±391 days. Mean (±SD) baseline T‐score, Z‐score, and BMD (from spine, hips and femurs) (g/cm2) was ‐0.3±1.09, ‐0.06±0.93, and 1.05±0.15 respectively. Mean (±SD) change in bone mineral density was +0.38%±1.5% with mean change in absolute BMD of ‐0.01±0.04 g/cm2 (p=0.3). One patient progressed from normal BMD to osteopenia and none from osteopenia to osteoporosis. Conclusion Chronic maintenance steroid therapy in this pilot study does not appear to induce significant change in BMD in patients with EoE. Larger and longer trials are needed to validate these conclusions.
- 7 May 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (12) , 3568-3578
Eosinophilic Esophagitis Is Rarely Continually Symptomatic 10 Years After an Initial Treatment Course in Adults
Despite its initial description over 25 years ago, there is little known about the course of eosinophilic esophagitis (EoE) after an initial course of medical or dietary treatment. We aim to assess the long-term symptomology and quality of life (QoL) metrics in patients 10 years after initial treatment for eosinophilic esophagitis.
- 7 May 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (12) , 3568-3578
Eosinophilic Esophagitis Is Rarely Continually Symptomatic 10 Years After an Initial Treatment Course in Adults
Despite its initial description over 25 years ago, there is little known about the course of eosinophilic esophagitis (EoE) after an initial course of medical or dietary treatment. We aim to assess the long-term symptomology and quality of life (QoL) metrics in patients 10 years after initial treatment for eosinophilic esophagitis.
- 24 July 2018
- Published by Springer Nature in Dysphagia
- Vol. 34 (1) , 138-144
Poor Relationship Between Fractionated Exhaled Nitric Oxide and Disease Activity in Eosinophilic Esophagitis
Current eosinophilic esophagitis care requires monitoring with repeat endoscopy and biopsy, which has significant cost, risk, and inconvenience for patients. Fractionated exhaled nitric oxide testing (FeNO) is a standardized non-invasive test with proven utility in evaluation of asthma. Elevated FeNO has reported use in other eosinophilic inflammatory conditions; however, its use in eosinophilic esophagitis has not been fully evaluated. To assess the utility of FeNO in predicting severity of eosinophilic esophagitis activity. Fifty patients received fractionated exhaled nitric oxide testing within 1 week of endoscopic evaluation with biopsy for determination of peak eosinophil counts. Presence of furrows was also evaluated with respect to FeNO levels. Spearman correlation was calculated between FeNO and peak eosinophil counts (PEC) with subgroup analysis performed based on PPI use. Spearman correlation was performed on the change in FeNO and PEC on the patients receiving repeat testing. FeNO was poorly correlated to PEC (Spearman correlation 0.22). With a cut-off FeNO value of > 40 ppb, specificity of FeNO for detecting presence of ≥ 15 eos/hpf was 0.94 and sensitivity was 0.16. FeNO showed weak relationship to presence of furrows. Within the subgroup of patients not taking PPI, the spearman correlation was 0.21. Delta- FeNO versus Delta-PEC had spearman correlation of 0.72 for patients receiving repeat testing. FeNO likely has limited clinical utility for predicting severity of esophageal eosinophilia. In patients with FeNO levels > 40 ppb, specificity of testing was high, but very few patients reached this FeNO level.
- 24 July 2018
- Published by Springer Nature in Dysphagia
- Vol. 34 (1) , 138-144
Poor Relationship Between Fractionated Exhaled Nitric Oxide and Disease Activity in Eosinophilic Esophagitis
Current eosinophilic esophagitis care requires monitoring with repeat endoscopy and biopsy, which has significant cost, risk, and inconvenience for patients. Fractionated exhaled nitric oxide testing (FeNO) is a standardized non-invasive test with proven utility in evaluation of asthma. Elevated FeNO has reported use in other eosinophilic inflammatory conditions; however, its use in eosinophilic esophagitis has not been fully evaluated. To assess the utility of FeNO in predicting severity of eosinophilic esophagitis activity. Fifty patients received fractionated exhaled nitric oxide testing within 1 week of endoscopic evaluation with biopsy for determination of peak eosinophil counts. Presence of furrows was also evaluated with respect to FeNO levels. Spearman correlation was calculated between FeNO and peak eosinophil counts (PEC) with subgroup analysis performed based on PPI use. Spearman correlation was performed on the change in FeNO and PEC on the patients receiving repeat testing. FeNO was poorly correlated to PEC (Spearman correlation 0.22). With a cut-off FeNO value of > 40 ppb, specificity of FeNO for detecting presence of ≥ 15 eos/hpf was 0.94 and sensitivity was 0.16. FeNO showed weak relationship to presence of furrows. Within the subgroup of patients not taking PPI, the spearman correlation was 0.21. Delta- FeNO versus Delta-PEC had spearman correlation of 0.72 for patients receiving repeat testing. FeNO likely has limited clinical utility for predicting severity of esophageal eosinophilia. In patients with FeNO levels > 40 ppb, specificity of testing was high, but very few patients reached this FeNO level.
- 18 January 2018
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 63 (3) , 694-702
Efficacy of Atopy Patch Testing in Directed Dietary Therapy of Eosinophilic Esophagitis: A Pilot Study
Background Atopy patch testing (APT) has shown potential for predicting dietary food triggers in studies of children and adolescents with eosinophilic esophagitis (EoE). Aims To assess the efficacy of APT in adults with EoE. Methods We conducted a prospective open-label pilot study of patients ≥ 18 years old with diagnosis of EoE at Mayo Clinic in Rochester, Minnesota, from November 2014 to January 2016. All patients underwent patch testing using intact food products, followed by a six food elimination diet and stepwise food reintroduction. Response to elimination diet was assessed with serial endoscopy with biopsies as well as clinical symptoms. APT results were directly compared to elimination diet results for assessment of efficacy. Correlation between clinical symptoms, endoscopic score, and histology was also qualitatively evaluated. Results Fifty percent of the patients had a positive APT, while only 16% had an APT result confirmed histologically during food reintroduction. Sensitivity of APT was calculated to be 5.9%, with specificity of 92.0%. Furthermore, we found significant qualitative inter-patient heterogeneity in the correlation between clinical symptoms, EREFS score, and histology. Conclusions APT does not reliably predict food triggers identified by food elimination diet in adult patients with EoE. As a result, APT does not have a clear role in the evaluation of patients with EoE.
- 18 January 2018
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 63 (3) , 694-702
Efficacy of Atopy Patch Testing in Directed Dietary Therapy of Eosinophilic Esophagitis: A Pilot Study
Background Atopy patch testing (APT) has shown potential for predicting dietary food triggers in studies of children and adolescents with eosinophilic esophagitis (EoE). Aims To assess the efficacy of APT in adults with EoE. Methods We conducted a prospective open-label pilot study of patients ≥ 18 years old with diagnosis of EoE at Mayo Clinic in Rochester, Minnesota, from November 2014 to January 2016. All patients underwent patch testing using intact food products, followed by a six food elimination diet and stepwise food reintroduction. Response to elimination diet was assessed with serial endoscopy with biopsies as well as clinical symptoms. APT results were directly compared to elimination diet results for assessment of efficacy. Correlation between clinical symptoms, endoscopic score, and histology was also qualitatively evaluated. Results Fifty percent of the patients had a positive APT, while only 16% had an APT result confirmed histologically during food reintroduction. Sensitivity of APT was calculated to be 5.9%, with specificity of 92.0%. Furthermore, we found significant qualitative inter-patient heterogeneity in the correlation between clinical symptoms, EREFS score, and histology. Conclusions APT does not reliably predict food triggers identified by food elimination diet in adult patients with EoE. As a result, APT does not have a clear role in the evaluation of patients with EoE.
- 1 January 2018
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 28 (1) , 47-57
Endoscopic and Radiologic Findings in Eosinophilic Esophagitis
- 1 January 2018
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 28 (1) , 47-57
Endoscopic and Radiologic Findings in Eosinophilic Esophagitis